Alzheimer Disease Diagnostics Market Will Grow Rapidly In Coming Years
The global Alzheimer’s disease diagnostics market is moving toward earlier, more precise, and less invasive detection as healthcare systems respond to the growing burden of Alzheimer’s disease and an aging population. According to Grand View Research, the market was valued at USD 9.2 billion in 2025 and is estimated to reach USD 10.2 billion in 2026 . It is projected to reach USD 21.5 billion by 2033 , expanding at a CAGR of 11.2% from 2026 to 2033 . North America held the largest regional share at 47.5% in 2025, while Asia Pacific is expected to be the fastest-growing region. AI is becoming an important supporting technology for Alzheimer’s diagnostics. AI-enabled imaging software can analyze MRI and other neurological images, while machine learning can help interpret biomarkers, genetic information, and clinical data. Recent research is also moving toward multimodal AI that combines imaging, blood biomarkers, cognitive assessments, and longitudinal patient information. T...